This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Savara Inc. is a clinical-stage pharmaceutical company developing novel therapies for serious rare respiratory diseases. Its drug development pipeline, as documented in its SEC filings, relies on preclinical animal studies to assess the safety and efficacy of its investigational products. The company's Form 10-K explicitly notes that its Investigational New Drug (IND) applications include results from animal trials conducted in accordance with FDA requirements.
This reliance on animal testing is a standard but exclusionary component of its business model. As a biotechnology firm advancing new chemical entities through regulatory pathways, Savara's operations are intrinsically linked to the commercial exploitation of animals for laboratory research, falling under the general animal exploitation criteria.
Savara Inc. is a clinical-stage biopharmaceutical company whose product development pipeline relies on animal testing as a standard component of preclinical research. The company’s public filings, including its annual Form 10-K reports, explicitly cite the “completion of preclinical laboratory tests and animal studies” as a routine part of its development process for investigational drugs. This practice is integral to its business model, as Savara develops inhaled therapies for rare respiratory diseases, a process that typically requires extensive animal data to support regulatory submissions to agencies like the U.S. Food and Drug Administration.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.